Metlife Inc
MET- Exchange
- NYSE
- Industry
- Life Insurance
- SEC CIK
- 0001099219
No open-market purchases or sales by Metlife Inc insiders were filed in the last 90 days; 1,450 institutions reported holding it in 13F filings for Q2 2026, worth $41.0B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +83 vs. previous quarter
- 1,450
- 13F valueReported value at the end of Q2 2026
- $41.0B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MET, Q2 2026
No superinvestor reported holding MET at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Metlife Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Debel MarleneEVP & Chief Risk Officer | SSale | −21.3K | $81.59 | −$1.74M | −12.1%154.4K after | |
| May 13, 2025 (view filing) | May 12 | 1 day | Pappas BillEVP, Global Tech. & Ops. | SSale | −26.0K | $80.49 | −$2.09M | −28.0%66.7K after | |
| Dec 17, 2024 (view filing) | Dec 13 | 4 days | Debel MarleneEVP & Chief Risk Officer | SSale | −22.8K | $82.88 | −$1.89M | −17.4%108.5K after | |
| Dec 17, 2024 (view filing) | Dec 13 | 4 days | Khalaf MichelPresident & CEO | SSale | −20.9K | $82.84 | −$1.73M | −4.0%500.8K after | |
| Mar 20, 2024 (view filing) | Mar 18 | 2 days | Pappas BillEVP, Global Tech. & Ops. | SSale | −27.0K | $72.27 | −$1.95M | −31.9%57.8K after | |
| Mar 14, 2024 (view filing) | Mar 13 | 1 day | Tadros RamyPresident, U.S. Business | SSale | −4.03K | $71.90 | −$289.5K | −2.7%147.0K after | 10b5-1 |
| Feb 7, 2024 (view filing) | Feb 5 | 2 days | Khalaf MichelPresident & CEO | SSale | −20.5K | $65.95 | −$1.35M | −5.0%386.0K after | |
| Dec 18, 2023 (view filing) | May 19 | 213 daysLate | Johnson Jeh C.Director | PPurchase | +17 | $51.69 | +$878.73 | +0.7%2.53K after | |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Debel MarleneEVP & Chief Risk Officer | SSale | −9.39K | $63.18 | −$593.3K | −10.8%77.6K after | |
| Apr 19, 2023 (view filing) | May 6, 2022 | 348 daysLate | Hubbard Robert GlennDirector | PPurchase | +132 | $67.44 | +$8.90K | +0.2%85.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Metlife Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 51,786,925 | $4.38B | 0.07% | +363,045+0.7% | Added |
| Dodge & Cox | 48,431,150 | $4.10B | 2.15% | −2,683,626−5.3% | Reduced |
| Vanguard Capital Management LLC | 35,483,789 | $3.00B | 0.06% | −373,028−1.0% | Reduced |
| Vanguard Portfolio Management LLC | 30,031,431 | $2.54B | 0.11% | −782,010−2.5% | Reduced |
| State Street Corp | 25,336,999 | $2.14B | 0.06% | +116,610+0.5% | Added |
| Price T Rowe Associates Inc | 21,284,689 | $1.80B | 0.18% | −1,502,549−6.6% | Reduced |
| Geode Capital Management, LLC | 13,309,884 | $1.14B | 0.06% | +65,608+0.5% | Added |
| Morgan Stanley | 12,532,097 | $1.06B | 0.06% | +1,411,340+12.7% | Added |
| Pzena Investment Management LLC | 11,130,983 | $941.8M | 2.76% | −172,836−1.5% | Reduced |
| Dimensional Fund Advisors LP | 7,190,673 | $608.5M | 0.11% | +67,509+0.9% | Added |